Drugs Online » Prescription Drugs 8 » Glez Glucotrol
Glipizide is an anti-diabetic drug (sulfonylurea-type) used along with a proper diet and exercise program to control high blood sugar. It is used in patients with type 2 diabetes (non-insulin-dependent diabetes). It works by stimulating the release of your body's natural insulin. Controlling high blood sugar helps prevent kidney damage blindness nerve problems loss of limbs and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke.
Buy Glez Glucotrol and other Prescription Drugs 8 products online
at Medstore.
Buy Online at Medstore - Click Here!

About Glez Glucotrol:
Product Type: Prescription Drugs 8
Glez ( Glucotrol Generic Glipizide )
Glez (Glucotrol Generic Glipizide)
Glucotrol Generic Glipizide
2.5mg 2.5mg Tabs 5mg Tabs 100 Tablets 200 Tablets 400 Tablets 30 (3 x 10)
Glucotrol Generic Glipizide Glez

View more
Prescription Drugs 8
Previous Product Next Product
Drugs Online:
From Gulf News: Runners should avoid prescription drugs. Statins may increase production of the enzyme creatine kinase, and hence heighten chances of muscle damage in athletes. Marathon running has increased in popularity over the past three decades, with participation in the United States rising from 25,000 runners in 1976 to nearly 470,000 in 2008. Many professional and recreational runners take prescription drugs, unaware of potential side-effects that affect runners in particular. One such class of drugs, called statins, which includes medicines such as Lipitor, Crestor and Pravachol, lowers blood cholesterol by inhibiting a cholesterol-producing enzyme and may even lower the risks of heart attack and further cardiovascular disease in a narrow category of patients. A new study forthcoming in the American Journal of Cardiology examined the effect of statins on creatine kinase (CK), an enzyme linked to muscle damage. Elevated levels of CK in the blood and muscle after exercise correlates with muscle damage. The study, conducted by Dr Beth Parker of the Henry Low Heart Centre at Connecticut's Hartford Hospital, is the first to measure CK levels in athletes taking statins after physical activity in a real-life environment rather than in a university laboratory.


|